PHATHOM PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $0 | — |
| FY2018 | — | $-1.3M | $879.0K |
| FY2019 | $22.8M | $228.0M | $243.8M |
| FY2020 | $39.6M | $194.3M | $287.5M |
| FY2021 | $89.7M | $72.2M | $183.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $0 | — |
| FY2018 | — | $-1.3M | $879.0K |
| FY2019 | $22.8M | $228.0M | $243.8M |
| FY2020 | $39.6M | $194.3M | $287.5M |
| FY2021 | $89.7M | $72.2M | $183.3M |